Lung cancer, the second-most common cancer in the U.S., is often associated with smoking — but even those who have never had ...

During a live event, Neal E. Ready, MD, and participants discussed what factors justify using PD-1 plus CTLA-4 inhibitor and ...

Lung cancer is a big problem. It claims many lives each year. Around 160,000 people die annually in the US. This figure is higher than that of colon, breast, and prostate cancers combined. This shows ...

This trial is looking at gemcitabine and carboplatin chemotherapy with a new drug called apatorsen for people with non small cell lung cancer (NSCLC).

This study aims to identify relationships between standardized PET and CT radiomics features and pathological metrics in patients with lung adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC).

CHICAGO — Results from an international clinical trial show that a 14-gene molecular assay can help identify patients with early-stage non-squamous non-small cell lung cancer (NSCLC) who could benefit ...

Non-Small Cell Lung Cancer (NSCLC) represents up to 85% of all malignant lung nodules. Adenocarcinoma and squamous cell carcinoma account for 90% of all NSCLC histotypes. The standard diagnostic ...

In patients with head and neck squamous cell carcinoma (HNSCC), low-dose CT achieved higher sensitivity than chest x-ray for detecting lung metastases and second primary lung cancer, but patients ...

The facts on small-cell lung cancer, or SCLC, and non-small-cell lung cancer, or NSCLC, like symptoms, prognosis, treatment, and recovery.

While early non-small-cell lung cancer often doesn’t cause symptoms, your diagnosis may begin during a routine screening with a CT scan. This scan shows areas of your lungs that could have early ...